YoVDO

CONQUEST: A Platform Clinical Trial for Scleroderma-Associated Lung Disease

Offered By: SRFCURE via YouTube

Tags

Clinical Trials Courses Rheumatology Courses Pulmonology Courses Medical Research Courses Biopharmaceuticals Courses Scleroderma Courses Interstitial Lung Disease Courses Systemic Sclerosis Courses

Course Description

Overview

Save Big on Coursera Plus. 7,000+ courses at $160 off. Limited Time Only!
Learn about CONQUEST, an innovative phase 2b international platform clinical trial accelerating scleroderma research. Explore how this multicenter study, developed by the SRF and partner biopharmaceutical companies, investigates multiple therapies for treating interstitial lung disease (ILD) associated with systemic sclerosis (SSc-ILD). Gain insights from experts Dr. Toby Maher, Professor of Clinical Medicine at Keck School of Medicine of USC, and Dr. Dinesh Khanna, Professor of Medicine at the University of Michigan, as they present the groundbreaking approach to advancing treatments for this complex condition.

Syllabus

CONQUEST, a Platform Clinical Trial


Taught by

SRFCURE

Related Courses

Vaccine Trials: Methods and Best Practices
Johns Hopkins University via Coursera Fundamentals of Clinical Trials
Harvard University via edX Vaccinology
CNAM via France Université Numerique Health Technology Assessment: Choosing Which Treatments Get Funded
The University of Sheffield via FutureLearn Introduction to Applied Biostatistics: Statistics for Medical Research
Osaka University via edX